Site Notice

Information pursuant to Sect. 5 German Telemedia Act (TMG)

GENERATE e.V. vertreten durch PD Dr. Frank Leypoldt
Arnold-Heller-Str.3
c/o UKSH, Institut für Klinische Chemie und Klinik für Neurologie
24105 Kiel

Register of Associations: 5724
Registration court: Amtsgericht Münster

Represented by:
Vertreten durch Vorstand: PD Dr. Frank Leypoldt und PD Dr. Nico Melzer

Contact

Phone: 0431-500-61548
Telefax: 0431-500-16204
E-mail: info@generate-net.de

Person responsible for editorial

GENERATE e.V. vertreten durch PD Dr. Frank Leypoldt
c/o UKSH, Institut für Klinische Chemie und Klinik für Neurologie
Arnold-Heller-Str.3
24105 Kiel

EU dispute resolution

The European Commission provides a platform for online dispute resolution (ODR): https://ec.europa.eu/consumers/odr/.
Our e-mail address can be found above in the site notice.

Dispute resolution proceedings in front of a consumer arbitration board

We are not willing or obliged to participate in dispute resolution proceedings in front of a consumer arbitration board.

 

 

Layout & technical implementation:

Webentwicklung Petra Dammann
System: Contao Open Source CMS

 

Purpose of this website

This website provides information about autoimmune encephalitides and related diseases. It additionally posts evidence relating to diagnosis and therapy. Another aim of this website is to make it easier for the website visitor to find centers specialized in autoimmune encephalitis.
The content offered on this website is intended for the colleagues invested in the GENERATE network, interested members of the medical community and, of course, for the patients and their relatives affected by these diseases. The content posted on nmdare.org is only designed to foster, not replace the relationship between patients/website visitors and their physicians.

Advertising policy and funding sources

The generate-net.de website does not post nor is it financially sponsored by advertising or commercial ads.

Centers

Find a center near you here.

Latest news

GENERATE e.V. is nominated for the International Life Sciences Awards 2024

GENERATE-Patient*innenforum

GENERATE läd Betroffene und Angehörige am 06. Juli 2024 zum gemeinsamen Webinar ein.

NEMOS Patiententag 2023 in Frankfurt am Main

NEMOS läd Betroffene sowie Angehörige am 19.10.2023 zum Patiententag ein: nemos-net.de

Upcoming events

Currently there are no events.

References

Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell-mediated limbic encephalitis.

Gallus M, Roll W, Dik A, Barca C, Zinnhardt B, Hicking G, Mueller C, Naik VN, Anstötz M, Krämer J, Rolfes L, Wachsmuth L, Pitsch J, van Loo KMJ, Räuber S, Okada H, Wimberley C, Strippel C, Golombeck KS, Johnen A, Kovac S, Groß CC, Backhaus P, Seifert R, Lewerenz J, Surges R, Elger CE, Wiendl H, Ruck T, Becker AJ, Faber C, Jacobs AH, Bauer J, Meuth SG, Schäfers M, Melzer N. Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell-mediated limbic encephalitis. Sci Adv. 2023 Jun 9;9(23):eabq7595. doi: 10.1126/sciadv. abq7595. Epub 2023 Jun 9. PMID: 37294768; PMCID: PMC10256169.

Crebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis.

Räuber S, Schroeter CB, Strippel C, Nelke C, Ruland T, Dik A, Golombeck KS, Regner-Nelke L, Paunovic M, Esser D, Münch C, Rosenow F, van Duijn M, Henes A, Ruck T, Amit I, Leypoldt F, Titulaer MJ, Wiendl H, Meuth SG, Meyer Zu Hörste G, Melzer N. Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis. J Autoimmun. 2023 Feb;135:102985. doi: 10.1016/j.jaut.2022.102985. Epub 2023 Jan 6. PMID: 36621173.

Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis

Brändle SM, Cerina M, Weber S et al. PNAS March 2, 2021 118 (9) e1916337118.

Dieses Paper wurde vom Research4Rare Verbund zum Paper of the Month gewählt und erscheint im April dieses Jahres im BMBF Newsletter!

A Therapeutic Non-self-reactive
SARS-CoV-2 Antibody
Protects from Lung Pathology
in a COVID-19 Hamster Model

Kreye J, Momsen Reincke S, Kornau HC et al.
Cell. 2020 Nov 12;183(4):1058-1069.e19.

CD8+ T-Lymphocyte–Driven Limbic
Encephalitis Results in Temporal Lobe
Epilepsy

Pitsch J, van Loo KMJ, Gallus M et al.
Ann Neurol. 2021; 00:1-20.

Low CSF CD4/CD8+ T-cell proportions are associated with blood-CSF barrier dysfunction in limbic encephalitis.

Hansen N, Schwing K, Önder D, et al. Epilepsy Behav. 2020;102:106682.



Support Group Autoimmunenzephalitis: